These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2791491

  • 1. Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
    Neu HC, Saha G, Chin NX.
    Diagn Microbiol Infect Dis; 1989; 12(3):283-5. PubMed ID: 2791491
    [Abstract] [Full Text] [Related]

  • 2. Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods.
    Pankuch GA, Jacobs MR, Rittenhouse SF, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2317-22. PubMed ID: 7840563
    [Abstract] [Full Text] [Related]

  • 3. Susceptibilities of 97 strains of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
    Ismaeel NA.
    Microbios; 1997 Oct; 91(367):97-103. PubMed ID: 9467924
    [Abstract] [Full Text] [Related]

  • 4. Susceptibility of 100 strains of Stenotrophomonas maltophilia to three beta-lactams and five beta-lactam-beta-lactamase inhibitor combinations.
    Lecso-Bornet M, Bergogne-Bérézin E.
    J Antimicrob Chemother; 1997 Nov; 40(5):717-20. PubMed ID: 9421322
    [Abstract] [Full Text] [Related]

  • 5. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW, Weeks LS, Aldridge KE.
    Diagn Microbiol Infect Dis; 1992 Feb; 15(4):321-30. PubMed ID: 1611847
    [Abstract] [Full Text] [Related]

  • 7. Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2905-7. PubMed ID: 7695281
    [Abstract] [Full Text] [Related]

  • 8. Double-disk synergy test positivity in Stenotrophomonas maltophilia clinical strains.
    Hejnar P, Kolár M, Chmela Z.
    Folia Microbiol (Praha); 2004 Dec; 49(1):71-4. PubMed ID: 15114869
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
    Matsuyama JR, Beail B, Wallis C, Zeleznik D, Tartaglione T.
    Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303
    [Abstract] [Full Text] [Related]

  • 11. Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.
    Visalli MA, Jacobs MR, Moore TD, Renzi FA, Appelbaum PC.
    Antimicrob Agents Chemother; 1997 Apr; 41(4):767-70. PubMed ID: 9087486
    [Abstract] [Full Text] [Related]

  • 12. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.
    Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K.
    Antimicrob Agents Chemother; 1994 Mar; 38(3):624-7. PubMed ID: 8203865
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative in vitro activities of seven new beta-lactams, alone and in combination with beta-lactamase inhibitors, against clinical isolates resistant to third generation cephalosporins.
    Gupta V, Datta P, Agnihotri N, Chander J.
    Braz J Infect Dis; 2006 Feb; 10(1):22-5. PubMed ID: 16767311
    [Abstract] [Full Text] [Related]

  • 15. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases.
    Jacoby GA, Carreras I.
    Antimicrob Agents Chemother; 1990 May; 34(5):858-62. PubMed ID: 2193623
    [Abstract] [Full Text] [Related]

  • 16. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
    García-Rodríguez JA, García Sánchez JE, García García MI, García Sánchez E, Muñoz Bellido JL.
    Diagn Microbiol Infect Dis; 1991 May; 14(3):239-43. PubMed ID: 1889176
    [Abstract] [Full Text] [Related]

  • 17. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA, Hare R, Papa E, Adam C, Miller GH.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
    Arpi M, Victor MA, Mortensen I, Gottschau A, Bruun B.
    APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics.
    Hornstein MJ, Jupeau AM, Scavizzi MR, Philippon AM, Grimont PA.
    Antimicrob Agents Chemother; 1985 May; 27(5):806-11. PubMed ID: 2990327
    [Abstract] [Full Text] [Related]

  • 20. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C, Xie W, Zhang W, Ye Z, Wu H.
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.